Member-only story

#17 — The Role of Generative AI in Pharmaceutical Research: Revolutionizing Drug Discovery and bringing it to the Market

Drive Growth | Devang Soni
3 min readDec 19, 2023
Photo by Markus Spiske on Unsplash

Introduction:

Generative Artificial Intelligence (AI) is impacting all industries, and the pharmaceutical industry is no exception. The pharma industry has always been leading the charts in innovation and the quest to develop new drugs for old and new diseases. We will spend a few minutes here going through the impact that Generative AI is making in research, drug discovery, and the broader healthcare industry.

AI in Drug Discovery

  1. Compound Selection: Making drugs involves identifying the compounds that interact with biological targets to treat diseases. Usually, the process to analyze these individual chemicals to make compounds can takes months, if not years, and has been a very tedious and time-consuming process. With the introduction of AI, the algorithms can now analyze these chemical libraries to identify the best selection of compounds that can impact the biological targets. This process can help through a rapid selection of multicompounds to target the diseases and can significantly help with the drug discovery, reducing cost and time involved.
  2. Clinical Trials & Human Trials: The trials are long, consuming time and effort along with approvals from the agencies…

Create an account to read the full story.

The author made this story available to Medium members only.
If you’re new to Medium, create a new account to read this story on us.

Or, continue in mobile web

Already have an account? Sign in

Drive Growth | Devang Soni
Drive Growth | Devang Soni

Written by Drive Growth | Devang Soni

Board Member | Venture Investor | Digital & Technology Transformation | Finance & Business Strategy | Topics - Health, Fitness, STEM, Data, AI, Transformation

No responses yet

Write a response